Ann: UPDATE ON LITIGATION AGAINST PRIME, page-5

in 2015 annual report, MEM internally values prIME at 27mil, that gives MEM 11mil@43% shares.

this valuation was pre cGMP acreditation. given prIME has received the accreditatiom in July, which allows itself to have second round of fund raising, which probably means it has more urgency to settle the deal than MEM does.

no investment will happen unless a valuation of current company is done by prIME, which then will automatically unlock the debt. without investment, the facility built cannot operate for long.

if u look at prIME corporate video on its website, it more looks like 100mil company than 20mil.

i believe MEM will at least settle for net of 5mil cash by selling its B share in very near term.